Search - tctmd.com

Displaying 341 - 360 of 390

Sort: Relevancy | Date

News Conference News TCT 2012

New Results from SYNTAX, SPIRIT Trials Presented

October 22, 2012

Presentation TCT 2012

Does CABG Convey a Survival Advantage Compared to PCI in Complex Patients and Lesions (and if so, why)?

Presenter: Patrick Serruys

October 22, 2012

News Industry News

Abbott Announces International Launch of the Absorb™ Bioresorbable Vascular Scaffold

September 25, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

News Conference News ESC 2012

PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease

Yael L. Maxwell

August 27, 2012

News Industry News

Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients

July 18, 2012

Presentation TVT 2012

SURTAVI Update

Presenter: Patrick Serruys

June 05, 2012

Presentation TVT 2012

Important Changes from VARC-2

Presenter: Patrick Serruys

June 04, 2012

Presentation TVT 2012

Justifying Moderate-Risk Patients

Presenter: Patrick Serruys

June 03, 2012

News Conference News EuroPCR 2012

Thrombectomy Results Underwhelming in AMI Patients

Jason Kahn

May 17, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

Presentation GI2 2012

10 Reasons Why the Metallic Drug-eluting Stent Should be Replaced by Bioresorbable Scaffold

Presenter: Patrick W. Serruys

April 12, 2012

Presentation GI2 2012

The beginning of the stent era: the true story

Presenter: Patrick W. Serruys

April 12, 2012

News Conference News ACC 2012

BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy

Jason Kahn

March 25, 2012

Presentation PCI Outcomes 2012

Controversy 2, Part A: The Case for Surgery in Patients with Complex Coronary Artery Disease

Presenter: Patrick W. Serruys

March 23, 2012

Presentation CTO 2012

The Interventionalist Speaks: When I Would Choose PCI for Left Main Disease: Lessons from SYNTAX at Four Years

Presenter: Patrick Serruys

February 22, 2012

Presentation CTO 2012

Strengths and Limitations of the Syntax Score

Presenter: Patrick Serruys

February 22, 2012

Presentation TCT 2012

Differential Healing Response in Acute Coronary Syndrome Versus Stable Coronary Artery Disease Patients 5 Years Following Early Generation DES Implantation: An Optical...

Presenter: Lorenz Raber, Bindu Kalesan, Sandro Baumgartner, Hector M. Garcia Garcia, Thomas Pilgrim, J?rn Justiz, Peter Wenaweser, Giulio G. Stefanini, Aris Moschovitis, Lutz Buellesfeld, Ahmed A. Khattab, Bernhard Meier, Peter Juni, Patrick W. Serruys, Stephan Windecker

January 03, 2012

Presentation TCT 2012

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in drug-eluting stents 9-13 months after implantation: in vivo-assessment with optical coherence...

Presenter: Juan Luis Guti?rrez-Chico, Lorenz R?ber, Evelyn Regar, Takayuki Okamura, Carlo di Mario, Stephan Windecker, Gerrit-Anne van Es, Patrick W. Serruys

January 03, 2012

Presentation TCT 2012

Three Year Outcomes Of Chronic Total Occlusion Treatment With Biolimus Eluting Biodegradable Polymer Stent Versus Sirolimus Eluting Permanent Polymer Stent In the LEADERS...

Presenter: Joanna J. Wykrzykowska, Patrick Serruys, Ton de Vries, Gerrit-Anne Van Es, Pawel Buszman, Axel Linke, Thomas Ischinger, Volker Klauss, Roberto Corti, Franz Eberli, William Wijns, Marie-Claude Morice, Robert Jan van Geuns, Peter Juni, Stephan Windecker, Carlo DiMario

January 03, 2012

Advertisement

New Results from SYNTAX, SPIRIT Trials Presented

Does CABG Convey a Survival Advantage Compared to PCI in Complex Patients and Lesions (and if so, why)?

Abbott Announces International Launch of the Absorb™ Bioresorbable Vascular Scaffold

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease

Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients

SURTAVI Update

Important Changes from VARC-2

Justifying Moderate-Risk Patients

Thrombectomy Results Underwhelming in AMI Patients

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

10 Reasons Why the Metallic Drug-eluting Stent Should be Replaced by Bioresorbable Scaffold

The beginning of the stent era: the true story

BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy

Controversy 2, Part A: The Case for Surgery in Patients with Complex Coronary Artery Disease

The Interventionalist Speaks: When I Would Choose PCI for Left Main Disease: Lessons from SYNTAX at Four Years

Strengths and Limitations of the Syntax Score

Differential Healing Response in Acute Coronary Syndrome Versus Stable Coronary Artery Disease Patients 5 Years Following Early Generation DES Implantation: An Optical...

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in drug-eluting stents 9-13 months after implantation: in vivo-assessment with optical coherence...

Three Year Outcomes Of Chronic Total Occlusion Treatment With Biolimus Eluting Biodegradable Polymer Stent Versus Sirolimus Eluting Permanent Polymer Stent In the LEADERS...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content